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Abstract We examined the electrocardiographic (ECG)
findings of centenarians and associated them with >360-
day survival. Physical and functional assessment, resting
electrocardiogram and laboratory tests were performed on
86 study participants 101.9±1.2 years old (mean±SD)
(70 women, 16 men) and followed for at least 360 days.
Centenarian ECGs were assessed for left ventricular hy-
pertrophy (LVH) according to the Romhilt–Estes score,
Sokolow–Lyon criteria and Cornell voltage criteria which
were positive for 12.8, 6.98, and 10.5 % of participants,
respectively. Fifty-two study participants (60 %) survived
≥360 days. Multivariate logistic regression analysis
revealed a negative relationship between 360-day survival
and the following: R II <0.45 mVadjusted for CRP (odds
ratio (OR) = 0.108, 95 % confidence interval
(CI)=0.034–0.341, P< .001), R aVF<0.35 mVadjusted
for CRP (OR=0.151, 95 % CI=0.039–0.584, P< .006),
Sokolow–Lyon voltage <1.45 mV adjusted for CRP
(OR=0.178, 95 % CI=0.064–0.492, P= .001), QRS
≥90 ms adjusted for CRP (OR = 0.375, 95 %
CI=0.144–0.975, P= .044), and Romhilt–Estes score ≥5
points adjusted for sex and Barthel Index (OR=0.459,
95 % CI=0.212–0.993, P= .048) in single variable ECG
models. QRS voltage correlated positively with systolic
and pulse pressure, serum vitamin B12 level, sodium,
calcium, phosphorous, TIMP-1, and eGFR. QRS voltage
correlated negatively with BMI, WHR, serum leptin, IL-
6, TNF-α, and PAI-1 levels. QRS complex duration cor-
related positively with CRP; QTc correlated positively
with TNF-α. Results suggest that Romhilt–Estes LVH
criteria scores ≥5 points, low ECG QRS voltages
(Sokolow–Lyon voltage <1.45 mV), and QRS complexes
≥90 ms are predictive of centenarian 360-day mortality.
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Background
Identification of electrocardiographic (ECG) findings pre-
dictive of centenarian survival would prove valuable in
the clinical setting. The ECG remains one of the most
ubiquitous diagnostic tools in medicine and is readily
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utilized for domiciled frail elderly patients. Survival prog-
nosis of centenarians is especially important for making
diagnostic and therapeutic decisions. Widespread specific
cardiac anomalies have been documented by ECG in
centenarians (Lakkireddy et al. 2003; Rabunal-Rey et al.
2012; Basile et al. 2012). Survival and ECG associations
have been studied by Rabunal-Rey et al. (2012) who
observed that atrial fibrillation is a prognostic factor for
mortality and by Basile et al. (2012) who did not describe
any ECG findings that are predictive of survival. While
mildly elevated blood pressure has been associated with
improved health status in centenarians (Szewieczek et al.
2011; Szewieczek et al. 2015a), consistently elevated
blood pressure may lead to left ventricular hypertrophy
(LVH). It follows then that a positive relationship between
ECG LVH features and centenarian survival would be
expected. However, LVH is a known risk factor for ische-
mic heart disease and death (Kannel et al. 1969; Kannel et
al. 1970). Estes et al. (2015) demonstrated that the
Romhilt–Estes score, traditionally used for ECG detection
of LVH, may be applied to predict adverse outcomes in
the general population. Despite poor correlation between
electrocardiographic and echocardiographic features of
LVH in centenarians (Martínez-Sellés et al. 2015), it
seems reasonable to explore a possible association be-
tween ECG findings, especially LVH features, and sur-
vival probability in this specific age group. We also stud-
ied associations between ECG features and a range of
clinical, metabolic, and inflammatory markers to ascertain
possible influence on ECG features.
Methods
Participants
The study was carried out from January 2007 to August
2013. The data regarding >100-year-old inhabitants of
Upper Silesia were obtained from the Silesian
Voivodeship Administration Office in Katowice. In the
year 2006, there were 389 centenarians living in Upper
Silesia, accounting for 0.008% of the total population of
the area. Eight percent of addressees responded posi-
tively to invitation letters.
The study comprised of eighty-six 100.9±1.2-year-
old (mean±SD) study participants (70 women and 16
men). The study group is defined in our previous papers
(Szewieczek et al. 2015a, b).
Measurements
Patient assessment comprised of a structured interview,
physical examination, functional assessment, resting elec-
trocardiography, and blood sampling. A detailed descrip-
tion of the methods used, beyond ECG analysis, is pre-
sented in our previous papers (Szewieczek et al. 2015a, b).
Romhilt–Estes score, Sokolow–Lyon criteria, and Cornell
voltage criteria were used to assess left ventricular hyper-
trophy (Buxton et al. 2006). An electrocardiogram (ECG)
was analyzed according to the ACC/AHA/HRS Clinical
Data Standards (Buxton et al. 2006) and considered nor-
mal if the following criteria were met: sinus rhythm, no
significant rhythm disorders, heart rate from 60 to 90/min,
electrical axis from −30 to 90, PR interval from 0.12 to
0.20 s, QRS complex duration from 0.06 to 0.11 s,
corrected QT interval (QTc, according to the Bazett’s
formula) ≤0.43 s in males, and ≤0.45 s in females, no
significant ventricular depolarization or repolarization
changes, negative Romhilt–Estes score, Sokolow–Lyon
criteria, and Cornell voltage criteria. QTc >0.45 s in males
or >0.46 s in females was considered prolonged QT.
Centenarians received follow-up phone calls at least
360 days after initial examination.
Statistical Analysis
Data was analyzed using STATISTICA software version
10 (StatSoft, Inc., USA; StatSoft Poland). Chi-square test,
V-square test, and Fisher’s exact test were used for cate-
gorical variables, and nonparametric Mann–Whitney U
test was used for quantitative variables to compare cente-
narians who survived 360 days with those who did not
survive 360 days. Multivariate binary logistic regression
was performed to assess electrocardiographic findings
associated with 360-day survival. The variables were
adjusted for clinical, functional, and laboratory factors.
Multivariate analysis with backward elimination included
variables that yielded P values of 0.1 or lower in the initial
univariate analysis. The Kaplan–Meier method was used
to estimate survival probability in subgroups of centenar-
ians with respect to select variables, while differences
between these subgroups were assessed with the
Wilcoxon–Gehan statistic. Variables were tested for the
value corresponding with the lowest P level. The non-
parametric Spearman’s rank correlation coefficient was
used to assess relationships between ECG, and clinical
and laboratory measures. P values <0.05 were considered
statistically significant.
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Ethics
The study protocol was approved by the Bioethical
Committee of the Medical University of Silesia. Written
informed consent was obtained from each participant
and/or their caregiver after the aim of the study, proto-
col, and risks were explained.
Results
Only seven study participants (8.14 %) presented with
normal ECGs. Sixty-three participants (73.3 %) had sinus
rhythm, 18 (20.9 %) had permanent atrial fibrillation, 1
had paroxysmal atrial fibrillation, 1 had paroxysmal atrial
flutter, 1 had an implanted DDD pacemaker, and 2 had
extrasinusal rhythms. Fifteen participants (17.4 %) pre-
sented with first-degree atrioventricular block, 17
(19.8 %) with right bundle branch block, and 4 (4.65 %)
with left bundle branch block. Twenty-seven participants
(31.4 %) had a prolonged QT interval. Electrocardio-
graphic Romhilt–Estes score, Sokolow–Lyon criteria,
and Cornell voltage criteria for LVH were positive for
12.8, 6.98, and 10.5 % of participants, respectively.
Fifty-two participants (60 %) survived 360 days or
more. The proportion of males who died (10 of 16) was
greater than females (24 of 70; P= .038). Beyond sex,
survivors, as compared to nonsurvivors, did not differ
significantly in most clinical variables (see Table 1 in
our previous paper: Szewieczek et al. (2015b)).
Nonsurvivors, when compared to survivors, had a lon-
ger QRS complex, right ventricular activation time and
QTc, lower R wave amplitude in leads II, aVF, V5, and
V6, and lower S wave amplitude in lead V1 (Table 1).
No significant differences were found with respect to the
proportion of participants with positive LVH, as tested
by the Sokolow–Lyon criteria, Cornell voltage criteria,
or Romhilt–Estes score. Participants with an R wave in
lead II < 0.45 mV, R wave in lead aVF <0.35 mV,
Sokolow–Lyon voltage (S wave in lead V1+R wave
in lead V5 or V6—whichever is greater) <1.45 mV, and
QRS complex duration ≥0.09 s had diminished 360-day
survival probability as compared with study participants
with higher or lower values, respectively (Fig. 1). Mul-
tivariate logistic regression analysis revealed a negative
relationship between 360-day survival and the follow-
ing: R wave in lead II <0.45 mVadjusted for CRP (odds
ratio (OR) = 0.108, 95 % confidence interval
(CI) = 0.034–0.341, P< .001), R wave in lead aVF
<0.35 mV adjusted for CRP (OR = 0.151, 95 %
CI = 0.039–0.584, P< .006), Sokolow–Lyon voltage
<1.45 mV adjusted for CRP (OR = 0.178, 95 %
CI=0.064–0.492, P= .001), QRS ≥90 ms adjusted for
CRP (OR=0.375, 95 % CI=0.144–0.975, P= .044),
and Romhilt–Estes score ≥5 adjusted for sex and Barthel
Index (OR=0.459, 95 % CI=0.212–0.993, P= .048) in
Table 1 ECG measures in the study group
Variable Survivors
(n = 52)
Nonsurvivors (n= 34) Survivors versus
nonsurvivors
Mean ± SD P
QRS complex duration (s) 0.11 ± 0.11 0.12 ± 0.14 0.045
Ventricular activation time in V1 (s) 0.03 ± 0.04 0.05 ± 0.04 0.002
Corrected QT interval (s) 0.44 ± 0.07 0.45 ± 0.03 0.045
R wave in the lead II (mV) 0.56 ± 0.26 0.34 ± 0.25 <0.001
R wave in aVF (mV) 0.31 ± 0.22 0.18 ± 0.14 0.005
S wave in V1 (SV1) (mV) 0.77 ± 0.55 0.52 ± 0.49 0.020
R wave in V5 (RV5) (mV) 1.16 ± 0.56 0.88 ± 0.52 0.031
R wave in V6 (RV6) (mV) 1.05 ± 0.54 0.74 ± 0.42 0.012
Maximal R wave in V5 or V6 (mV) 1.22 ± 0.56 0.92 ± 0.51 0.023
SV1 + RV5 or RV6 (mV) 1.99 ± 0.72 1.44 ± 0.75 <0.001
Romhilt–Estes 5. criterion (1 point if QRS duration >0.09 s) (points) 0.38 ± 0.49 0.68 ± 0.48 0.023
Romhilt–Estes 5. criterion positive results (n (%)) 20 (38.5) 23 (67.7) 0.008
Romhilt–Estes Score (points) 2.13 ± 2.09 3.00 ± 2.32 0.063
Romhilt–Estes Score positive results for probable LVH (LVH is likely with 4 or more points) (n (%)) 10 (19.2) 13 (38.2) 0.052
Romhilt–Estes Score positive results for LVH (LVH is present with 5 or more points) (n (%)) 4 (7.7) 7 (20.6) 0.079
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single ECG variable models. QRS amplitude correlated
positively with systolic blood pressure, pulse pressure
and serum vitamin B12, sodium, calcium, phosphorous,
and TIMP-1 levels, as well as with eGFR. QRS ampli-
tude correlated negatively with BMI, WHR, and serum
leptin, IL-6, TNF-α, and PAI-1. QRS complex duration
correlated positively with CRP and bilirubin level, and
negatively with eGFR. QTc interval correlated positive-
ly with TNF-α (Table 2).
Discussion
We found normal ECGs in 8.4 % of 86 study partici-
pants, which is consistent with other studies in the
literature. Normal ECGs were observed in 5.7 % of 35
(Klich-Raczka et al. 2003), 7.6 % of 132 (Lakkireddy et
al. 2003), 8.8 % of 80 (Rabunal-Rey et al. 2012), 16.7%
of 42 (Basile et al. 2012), and 26.2 % of 103 centenar-
ians (Martínez-Sellés et al. 2015) in different study
participants.
Commonly observed ECG abnormalities in our study
group included atrial fibrillation, conduction defects,
ST-segment depression, and left axis deviation. Perma-
nent atrial fibrillation in our patients (20.9 %) occurred
more frequently than observed by Klich-Raczka et al.
(2003) (8.6 %) and Basile et al. (2012) (11.9 %), but less
often than observed by Martínez-Sellés et al. (2015)
(26.2 %), Rabunal-Rey et al. (2012) (26.3 %), or
Lakkireddy et al. (2003) (29.5 %). Rabunal-Rey et al.
(2012) demonstrated that atrial fibrillation is an inde-
pendent risk factor for mortality. By contrast, Basile et
al. (2012) did not find significant differences in age of
death in relation to electrocardiographic findings.
Fig. 1 Kaplan–Meier survival probability of centenarians classi-
fied according to a amplitude of R wave in lead II ≥0.45 mV
versus lower values, b amplitude of R wave in lead II ≥0.35 mV
versus lower values, c Sokolow–Lyon voltage ≥1.45 mV versus
lower values, and d QRS complex duration <90 ms versus higher
values
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Table 2 Correlations between clinical or laboratory measures and ECG measures in centenarians (n = 86)




BMI (body mass index) R wave in II −0.213 0.049
R wave in V5 −0.245 0.023
R wave in V5 or V6 −0.233 0.031
S wave in V1+R wave in V5 or V6 −0.242 0.024
WHR (waist to hip ratio) S wave in V1+R wave in V5 or V6 −0.269 0.013
Systolic blood pressure R wave in II 0.261 0.015
R wave in aVF 0.307 0.004
R wave in V5 0.223 0.039
R wave in V5 or V6 0.262 0.015
S wave in V1 0.250 0.020
S wave in V1+R wave in V5 or V6 0.261 0.015
Pulse pressure Heart rate −0.316 0.003
R wave in aVF 0.239 0.026
R wave in V6 0.304 0.004
S wave in V1 0.316 0.003
S wave in V1+R wave in V5 or V6 0.335 0.002
CRPa QRS complex duration 0.216 0.049
Ventricular activation time in V1 0.302 0.005
Bilirubina QRS complex duration 0.256 0.019
Vitamin B12a S wave in V1 0.254 0.022
Leptinb R wave in V5 −0.331 0.030
Sodiumc R wave in II 0.327 0.025
Calciumc R wave in II 0.400 0.004
R wave in aVF 0.307 0.032
R wave in V5 0.316 0.027
R wave in V6 0.299 0.037
S wave in V1+R wave in V5 or V6 0.312 0.029
Phosphorus (inorganic)c S wave in V1 0.447 0.001
S wave in V1+R wave in V5 or V6 0.383 0.007
Cornell Voltage value (R wave in aVL+S
wave in V3)
0.445 0.001
eGFR (CKD-EPI creatinine–cystatin C
equation)
Heart rate −0.273 0.012
QRS complex duration −0.237 0.030
eGFR (BIS_creatinine-cystatin C equation) R wave in aVF 0.235 0.031
Interleukin 6b R wave in V5 −0.328 0.028
R wave in V6 −0.317 0.034
R wave in V5 or V6 −0.333 0.025
S wave in V1 −0.343 0.021
S wave in V1+R wave in V5 or V6 −0.526 0.000
Tumor necrosis factor alphab Corrected QT interval 0.307 0.040
Plasminogen activator inhibitor-1b S wave in V1 −0.347 0.023
Cornell Voltage value (R wave in aVL+S
wave in V3)
−0.489 0.001
Tissue inhibitor of metalloproteinases 1b Romhilt–Estes Score 0.313 0.041
a Serum level, assessed in 84 subjects
b Serum level, assessed in 43 subjects
c Serum level, assessed in 49 subjects
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Lakkireddy et al. (2003) and Martínez-Sellés et al.
(2015) did not report any relationship between ECG
findings and mortality in centenarians.
Electrocardiographic assessment was positive for left
ventricular hypertrophy in 6.98 to 12.8 % of participants
in our study (depending onwhich ECGLVH assessment
method was applied). In studies performed by
Lakkireddy et al. (2003) and Basile et al. (2012), ECG
features of LVH were found in 3 to 31 % of study
participants. Martínez-Sellés et al. (2015) used echocar-
diography to diagnose left ventricular hypertrophy in
45 % of 100 centenarians, while only 5.1 % had ECG
features of LVH. False-negative ECG-LVH may be
associated with hypertension, increased systolic blood
pressure, and prolonged QRS (Bacharova et al. 2015).
These factors commonly exist in centenarians
(Moubarak et al. 2012; Andersen-Ranberg et al. 2013;
Szewieczek et al. 2015a; Szewieczek et al. 2015b).
Regardless of accuracy, ECG-LVH is associated with
increased risk of cardiovascular events (Kannel et al.
1970; Bacharova et al. 2015; Porthan et al. 2015). Estes
et al. (2015) found that four out of the six ECG compo-
nents of the Romhilt–Estes score, beyond left axis devi-
ation and prolonged QRS duration, were predictive of
all-cause mortality in the general population. In previous
studies, we observed a positive relationship between
elevated blood pressure and 180-day survival
(Szewieczek et al. 2015a) and between hypertension
and 360-day survival (Szewieczek et al. 2015b) in
centenarians.
Based on the association between QRS voltage and
blood pressure (Van Hoof 1991), we expected a possible
positive association between electrocardiographic LVH
voltage criteria and survival in our study group. How-
ever, hypertension is a risk factor for left ventricular
hypertrophy that is associated with an increased risk of
ischemic heart disease, atrial fibrillation, heart failure,
and mortality (Kannel et al. 1969; Kannel et al. 1970;
Katholi and Couri 2011; Velagaleti et al. 2014; Cuspidi
et al. 2015). Indeed, QRS voltage correlated positively
with systolic blood pressure and pulse pressure (Table
2), and participants who survived 360 days had higher
QRS voltage (Fig. 1).
Interestingly, LVH defined by a Romhilt–Estes score
≥5 in our study group was associated with decreased
centenarian survival. This apparent contradiction may at
least partially be explained by the high QRS voltage of
the Romhilt–Estes LVH criteria (R wave amplitude
greater than 2.0 mV in limb leads or R wave amplitude
greater than 3.0 mV in leads V5 or V6) (Buxton et al.
2006). However, within our study population, we ob-
served decreased survival probability at QRS ampli-
tudes that were significantly lower than those suggested
by the Romhilt–Estes criteria. Similarly, we found that
the QRS amplitude cutoff for increased survival proba-
bility was also significantly lower (Fig. 1). These find-
ings suggest that a positive Romhilt–Estes test for LVH
and a low QRS voltage may be associated with de-
creased 360-day survival in our study group.
Low electrocardiographic QRS voltage (LQRSV) is
traditionally defined by zenith-to-nadir QRS amplitudes
of less than 0.5 mV in all limb leads and/or less than
1.0 mV in all the precordial leads (low limb, precordial,
or total QRS voltages) (Madias 2008; Mussinelli et al.
2013). Etiologic factors include multiple cardiac, peri-
cardial, and/or extra-cardiac causes (Madias 2008).
LQRSV has been identified as a risk factor for increased
mortality in individuals without apparent cardiovascular
disease (Usoro et al. 2014) and in patients with acute
coronary syndromes (Tan et al. 2015). Sokolow–Lyon
voltage ≤1.5 mV is an alternative index of low QRS
voltage (Austin et al. 2009). We were unable to prove an
association between 360-day mortality and low QRS
voltage in limb or precordial leads. Instead, we found
such an association with low amplitude Rwaves in leads
II and aVF, as well as a low Sokolow–Lyon voltage. The
pathophysiology of the association between mortality
and low amplitude of specific R waves in leads II and
aVF is unclear.
Associations between mortality and decreased QRS
voltage seem to be complex and may include common
pathologies such as cardiomyocyte changes, diffuse
myocardial fibrosis (Bacharova et al. 2015), and also
amyloidosis which may be substantially more common
than is currently recognized (Patel and Hawkins 2015).
Sokolow–Lyon voltage correlates positively with left
ventricular mass, left ventricular ejection fraction, and
negatively with myocardial fibrosis in patients with
hypertrophic cardiomyopathy (Konno et al. 2015).
Low QRS voltages were seen in 27.3 % of the light-
chain (AL) amyloidosis patients and 12.9 % of the wild-
type transthyretin amyloidosis (ATTRwt) patients
(Pinney et al. 2013). ATTRwt, also known as senile
cardiac amyloidosis, is an underdiagnosed disease that
accounts for a significant number of elderly patients with
heart failure with preserved ejection fraction (González-
López et al. 2015). Low Sokolow–Lyon voltage is asso-
ciated with a more severe myocardial infiltration in
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cardiac AL amyloidosis (Mussinelli et al. 2013) which
can occur at any age (Patel and Hawkins 2015).
Study participants who did not survive 360 days as
compared to survivors had a wider QRS complex, with
increased right ventricular activation time. QRS widen-
ing is associated with increased risk for heart failure and
mortality (Khan et al. 2007). The QRS interval can be
affected by numerous factors, among them metabolic
and inflammatory markers (Vanninen et al. 1996;
Bacharova et al. 2012; Cetin et al. 2012). Focal or
diffuse myocardial fibrosis, edema, inflammation, myo-
carditis, fatty replacement, or myocardial deposition of
amyloid proteins may be determinants of myocardial
tissue (Bacharova and Ugander 2014).
Inflammatory markers are elevated in patients with
congestive heart failure and reflect disease severity
(Lommi et al. 1997; Feldman et al. 2000). These obser-
vations may be substantiated by multiple associations
between QRS voltage and various hemodynamic, met-
abolic, and inflammatory factors (systolic blood pres-
sure, pulse pressure, serum vitamin B12, sodium, calci-
um, phosporus, TIMP-1 levels, and eGFR) found in our
study, although elucidation of the significance of these
relationships would benefit from further study.
Nonsurvivors as compared to survivors also had a
longer QTc that correlated positively with TNF-α. QTc
contributes independently to cardiovascular risk
(Schouten et al. 1991). Kim et al. (2006) observed a
relationship between CRP and QTc in middle-aged men
and women. A similar relationship was observed in
young, healthy men (Kazumi et al. 2003). Vasan et al.
(2003) revealed an association between increased TNF-
alpha, IL-6, and CRP levels in elderly patients and
increased risk of congestive heart failure. Inflammation
associated with rheumatoid arthritis was found to affect
QTc (Panoulas et al. 2014).
Multiple metabolic and inflammatory factors may
affect centenarian survival, influence heart structure
and function, and therefore reflect characteristic ECG
findings. These findings are generally consistent with
other observations in the literature. As such, the impor-
tance of ECG characteristics as predictors of centenarian
survival may signify more than simply a reflection of the
cardiovascular health of the patient.
Criticism of the presented study encompasses low
inclusion rate of candidates, which resulted in an exten-
sion of the observation period. Additionally, this study
was based on a relatively small patient population. We
were unable to complement our study with
echocardiography that would substantially extend basis
for data interpretation. These difficulties resulted mainly
from the nature of the Polish centenarian cohort.
We demonstrated that a low QRS voltage and a wide
QRS complex may be predictive of 360-day mortality
among study participants. According to an extensive
literature search, this is the first such published observa-
tion in centenarians. Since ECG remains one of the most
accessible and noninvasive methods of health assess-
ment, these findings may be useful for making diagnostic
and therapeutic decisions in the oldest old patients.
Conclusions
Results suggest that Romhilt–Estes LVH criteria scores
≥5 points, low ECG QRS voltages (Sokolow–Lyon
voltage <1.45 mV), and QRS complexes ≥90 ms are
predictive of centenarian 360-day mortality.
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